Form 8-K - Current report:
SEC Accession No. 0001628280-24-039341
Filing Date
2024-09-04
Accepted
2024-09-04 16:42:05
Documents
14
Period of Report
2024-09-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K dna-20240903.htm   iXBRL 8-K 25934
  Complete submission text file 0001628280-24-039341.txt   196193

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20240903.xsd EX-101.SCH 2315
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20240903_def.xml EX-101.DEF 16478
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20240903_lab.xml EX-101.LAB 29228
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20240903_pre.xml EX-101.PRE 17276
16 EXTRACTED XBRL INSTANCE DOCUMENT dna-20240903_htm.xml XML 4173
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 241278112
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)